Borghetti, Alberto
 Distribuzione geografica
Continente #
EU - Europa 2.418
NA - Nord America 2.388
AS - Asia 945
SA - Sud America 104
AF - Africa 57
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 6
Totale 5.945
Nazione #
US - Stati Uniti d'America 2.333
IT - Italia 613
SE - Svezia 494
SG - Singapore 346
DE - Germania 295
CN - Cina 238
PL - Polonia 220
FR - Francia 206
IE - Irlanda 146
GB - Regno Unito 113
ID - Indonesia 93
BR - Brasile 92
FI - Finlandia 90
IN - India 73
UA - Ucraina 57
CA - Canada 44
RU - Federazione Russa 42
BE - Belgio 31
IR - Iran 27
AU - Australia 25
TR - Turchia 25
AT - Austria 24
NL - Olanda 24
SA - Arabia Saudita 19
HK - Hong Kong 18
CI - Costa d'Avorio 15
PH - Filippine 15
PK - Pakistan 12
CH - Svizzera 11
MY - Malesia 11
EG - Egitto 9
ES - Italia 9
VN - Vietnam 9
BD - Bangladesh 7
CZ - Repubblica Ceca 7
MA - Marocco 7
TN - Tunisia 7
TW - Taiwan 7
GR - Grecia 5
LT - Lituania 5
NG - Nigeria 5
ZA - Sudafrica 5
EU - Europa 4
IL - Israele 4
IQ - Iraq 4
JO - Giordania 4
MX - Messico 4
NP - Nepal 4
PT - Portogallo 4
RO - Romania 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
CO - Colombia 3
DK - Danimarca 3
JM - Giamaica 3
KG - Kirghizistan 3
MD - Moldavia 3
NO - Norvegia 3
SD - Sudan 3
TH - Thailandia 3
BG - Bulgaria 2
CL - Cile 2
CM - Camerun 2
JP - Giappone 2
KE - Kenya 2
LK - Sri Lanka 2
MG - Madagascar 2
MM - Myanmar 2
MO - Macao, regione amministrativa speciale della Cina 2
NZ - Nuova Zelanda 2
VA - Santa Sede (Città del Vaticano) 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AZ - Azerbaigian 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CY - Cipro 1
EC - Ecuador 1
GL - Groenlandia 1
IM - Isola di Man 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
MK - Macedonia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PY - Paraguay 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.945
Città #
Chandler 626
Singapore 267
Ashburn 240
Kraków 209
Milan 152
Dublin 143
Rome 136
New York 132
Jakarta 93
San Mateo 79
Helsinki 68
Jacksonville 60
Boston 59
Ann Arbor 48
Princeton 48
Wilmington 48
Marseille 43
Los Angeles 38
Redmond 33
Nanjing 32
Moscow 30
Beijing 29
Brussels 28
Chicago 28
Lancaster 27
Cattolica 26
London 23
Boardman 22
Houston 21
Dearborn 20
Pune 20
Fairfield 19
Lawrence 17
Vienna 17
Toronto 16
Woodbridge 16
Abidjan 15
Bremen 15
Munich 15
Nuremberg 15
Amsterdam 14
Augusta 14
Seattle 14
Redwood City 13
Washington 13
Hong Kong 12
Norwalk 12
Dammam 11
Izmir 11
Kish 11
Nürnberg 11
São Paulo 11
Falkenstein 10
Warsaw 10
Andover 9
Cambridge 9
Changsha 8
Ottawa 8
Sydney 8
Al Qatif 7
Frankfurt am Main 7
Guangzhou 7
Leawood 7
Padova 7
Paris 7
Phoenix 7
Santa Clara 7
Lahore 6
Oggiono 6
Shenyang 6
Zurich 6
Belo Horizonte 5
Cairo 5
Columbus 5
Delhi 5
Ferrara 5
Hefei 5
Jinan 5
Nanchang 5
Naples 5
Portland 5
St Louis 5
Swansea 5
Taipei 5
Tianjin 5
Amman 4
Bari 4
Boydton 4
Cape Town 4
Castelfranco Emilia 4
Falls Church 4
Hebei 4
Lappeenranta 4
Latina 4
Madrid 4
Robbiate 4
Sacramento 4
Shanghai 4
Springfield 4
Tashkent 4
Totale 3.392
Nome #
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 436
Prevalence of osteoporosis and predictors of low BMD in a cohort of HIV-1-infected patients in Rome: features of a population at high risk 172
Liver fibrosis is associated with cognitive impairment in HIV-positive patients 166
Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centre 161
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 155
Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2 years follow-up in HIV-infected patients 141
Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE) 136
Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients 134
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 128
Ophthalmic artery resistance index IS increased in HIV-Infected patients and is influenced by protease inhibitors exposure 124
Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial 121
Efficacy and safety of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study 111
Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy 107
Impact of 48 weeks of atazanavir/ritonavir plus lamivudine dual therapy on cellular HIV-DNA levels in the AtLaS pilot study 101
Retinal capillary involvement in early post-COVID-19 patients: a healthy controlled study 99
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 97
Baseline CD4(+) T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2-year follow-up in HIV-infected patients 96
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 94
Lipid-lowering effect and changes in estimated cardiovascular risk after switching to a tenofovir-containing regimen for the treatment of HIV-infected patients 93
Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 91
Psychological distress during the initial stage of the COVID-19 pandemic in an italian population living with HIV: An online survey 88
HIV-Related Internalized Stigma and Patient Health Engagement Model in an Italian Cohort of People Living With HIV 84
The University of California San Diego performance-based skills assessment: a useful tool to detect mild everyday functioning difficulties in HIV-infected patients with very good immunological condition 83
Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemic 80
Prevalence, incidence and predictors of anal high-risk HPV infections and cytological abnormalities in HIV-infected individuals 77
Shall we dance? Extending tango's results to clinical practice 75
Residual respiratory impairment after COVID-19 pneumonia 75
Difference in the neurocognitive functions of WLWH and MLWH in an Italian cohort of people living with HIV 75
Impact of the COVID-19 Pandemic on Health Care Is Negatively Associated With Psychosocial Well-Being in an Italian Cohort of People Living With HIV 74
Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients 73
Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line 73
Simplification to a dual regimen with darunavir/ritonavir plus lamivudine or emtricitabine in virologically-suppressed HIV-infected patients 68
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 68
Use of Long-Acting Therapies for HIV Care in Italy: Are People Living with HIV Prepared for Change? A Cross-Sectional Study 68
Use of telehealth for HIV care in Italy: Are doctors and patients on the same page? A cross-sectional study 65
Are we ready for long-acting? A feasibility evaluation of long-acting cabotegravir–rilpivirine in clinical practice 64
Impact of the M184V Resistance Mutation on Virological Efficacy and Durability of Lamivudine-Based Dual Antiretroviral Regimens as Maintenance Therapy in Individuals With Suppressed HIV-1 RNA: A Cohort Study 63
The University of California San Diego performance-based skills assessment: a useful tool to detect mild everyday functioning difficulties in HIV-infected patients with very good immunological condition 63
Seroprevalence of sars-cov-2 antibodies in hiv-infected patients in rome, italy during the covid-19 outbreak 61
Residual respiratory impairment after COVID-19 pneumonia 60
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort 59
Short Communication: Comparing Lamivudine+Dolutegravir and Bictegravir/Emtricitabine/Tenofovir Alafenamide as Switch Strategies: Preliminary Results from Clinical Practice 59
Risk of Tumor Onset in HIV+ Patients on Two-Drug Regimens: A Cohort Study in an Italian Hospital 59
Systemic inflammation markers after simplification to atazanavir/ritonavir plus lamivudine in virologically suppressed HIV-1-infected patients: ATLAS-M substudy 58
Derivation and validation of a scoring system to assess pre-test probability of being COVID-19 positive 58
No evidence of SARS-CoV-2 circulation in HIV-infected patients between December 2019 and February 2020 in Rome, Italy 55
SARS-CoV-2 infection in a highly experienced person living with HIV 54
People Living with HIV in the COVID-19 Era: A Case Report 53
Determinants of SARS-COV-2 seroconversion in a cohort of recovered patients 52
Still much to learn about the diagnostic role of SARS-CoV-2 antibody detection 49
Inflammation markers in virologically suppressed HIV-Infected patients after switching to dolutegravir plus lamivudine vs continuing triple therapy: 48-week results in real-life setting 48
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 48
Focal status epilepticus as unique clinical feature of COVID-19: A case report 48
Virological outcomes with dolutegravir plus either lamivudine or two NRTIs as switch strategies: a multi-cohort study 47
Cardiovascular Disease Risk in a Cohort of Virologically Suppressed People Living with HIV Switching to Doravirine: Preliminary Data from the Real Life 46
Functional associations between polymorphic regions of the human 3'IgH locus and COVID-19 disease 46
Off-label use of tocilizumab in patients with SARS-CoV-2 infection 45
Early use of tecovirimat in a young man with severe mpox skin lesions: a case report 44
The need to continue testing for HIV, even during the coronavirus disease 2019 (COVID-19) pandemic 41
Comparative safety review of recommended, first-line single-tablet regimens in patients with HIV 40
People Living with HIV in the COVID-19 Era: A Case Report 38
Transmitted drug resistance to NRTIs and risk of virological failure in naïve patients treated with integrase inhibitors 38
Older Age is Associated with Higher Dolutegravir Exposure in Plasma and Cerebrospinal Fluid of People Living with HIV 38
Implementing a Personalized Antimicrobial Stewardship Program for Women with Gynecological Cancers and Healthcare-Associated Infections 37
Short Communication: Efficacy and Safety of Dolutegravir plus Lamivudine as a First-Line Regimen in Clinical Practice 36
Biochemical and inflammatory modifications after switching to dual antiretroviral therapy in HIV-infected patients in Italy: A multicenter retrospective cohort study from 2007 to 2015 35
Integrase Inhibitors Use and Cytomegalovirus Infection Predict Immune Recovery in People Living With HIV Starting First-Line Therapy 33
No significant changes in body fat mass in virologically suppressed, HIV-positive patients switched to lamivudine-Dolutegravir 33
COVID-19 diagnosis does not rule out other concomitant diseases 33
Nucleoside Reverse-Transcriptase Inhibitor Resistance Mutations Predict Virological Failure in Human Immunodeficiency Virus-Positive Patients during Lamivudine plus Dolutegravir Maintenance Therapy in Clinical Practice 32
Comparison of HIV-DNA decay in naive patients starting dolutegravir plus lamivudine or dolutegravir-based triple therapy 32
Real-life findings on the impact of the COVID-19 pandemic on HIV care 32
HIV and vicarious stigma in a cohort of people living with HIV in Italy: What happens when the stigma is fueled by healthcare providers? 31
Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients 29
Kaposi-like manifestations in a newly diagnosed aids transgendered patient with silicone embolism syndrome and disseminated tuberculosis 26
Treatment of Aorto-iliac and Infrainguinal Vascular Infections with a Prefabricated Bovine Pericardial Graft 24
Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed 23
Differences in the Long-term Impact of the COVID-19 Pandemic on the Mental Health and Professional Quality of Life of Resident and Specialist Physicians 23
Predicting In-Hospital Mortality in COVID-19 Older Patients with Specifically Developed Scores 23
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 23
Nasopharingeal bacterial and fungal colonization in HIV-positive versus HIV-negative adults 23
The association between stigma and wellbeing in an Italian cohort of PLWH: The role of social support and personal factors 22
Dolutegravir Discontinuation for Neuropsychiatric Symptoms in People Living with HIV and Their Outcomes after Treatment Change: A Pharmacogenetic Study 22
Impact of resistance mutations on efficacy of dolutegravir plus rilpivirine or plus lamivudine as maintenance regimens: a cohort study 22
Blood telomere length gain in people living with HIV switching to dolutegravir plus lamivudine versus continuing triple regimen: a longitudinal, prospective, matched, controlled study 21
Letter to the Editor: Real-Life Experience of Long-Acting Cabotegravir-Rilpivirine Combination in a Person Living with HIV with Detectable Viremia: A Case Report 18
Atypical ductal hyperplasia on vacuum-assisted breast biopsy: a scoring system to predict the risk of upgrade to malignancy 18
The need to continue testing for HIV, even during the coronavirus disease 2019 (COVID-19) pandemic 17
Evolution of cellular HIV DNA levels in virologically suppressed patients switching to dolutegravir/lamivudine versus maintaining a triple regimen: a prospective, longitudinal, matched, controlled study 16
Clinical presentation of human monkeypox virus infection during the 2022 outbreak: descriptive case series from a large italian Research Hospital 16
Characteristics of mental health interventions in a cohort of Italian PLWH over the last five years: impact of HIV disease and outbreak of COVID-19 pandemic 15
Changes in Metabolic Profile in PLWHIV Switching to Doravirine-Based Regimen 14
Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemic 13
New insight of human-IgH 3′regulatory regions in immunoglobulins switch 11
Totale 6.076
Categoria #
all - tutte 32.362
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.362


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202095 0 0 0 0 0 0 0 14 13 16 34 18
2020/2021241 4 15 4 13 16 21 21 10 39 36 48 14
2021/2022714 35 21 16 74 20 23 65 116 31 56 89 168
2022/20232.072 212 261 181 332 210 273 87 158 221 56 62 19
2023/20241.149 44 229 37 102 62 187 80 33 41 58 141 135
2024/2025941 29 54 263 88 177 94 171 65 0 0 0 0
Totale 6.076